Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 174

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 174
---
any offering of debt securities of the Company, other than entering into a line of credit with a traditional bank, or (iv) enter into
any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital
stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of
shares of capital stock of the Company or such other securities, in cash or otherwise. Additionally, the Company’s directors and
officers and any other holder(s) of 10% or more of the issued and outstanding ordinary shares the outstanding shares of Common Stock
as of the effective date of the Registration Statement (and all holders of securities exercisable for or convertible into shares of Common
Stock) shall enter into customary “lock-up” agreements in favor of D. Boral pursuant to which such persons and entities shall
agree, for a period of sixty (60) days after the Closing of Offering, that they shall not offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into
or exercisable or exchangeable for shares of capital stock of the Company, subject to customary exceptions. The foregoing restrictions
shall also be contained and set forth in the Underwriting Agreement and customary “lock-up” agreements, as applicable.

<div align='center'>103</div>

Tail Financing

Subject to FINRA Rule 5110(g)(5)(B), the Representative is entitled to a cash fee equal to 7.0% of the aggregate gross proceeds received
by the Company from the sale of any equity, debt, and/or equity derivative instruments to any investor actually introduced by the Representative
to the Company during the engagement period of the Representative, in connection with any public or private financing or capital raise
(each a “Tail Financing”), and such Tail Financing is consummated at any time during the engagement period of the Representative
or within the 12-month period following the expiration or termination (except for termination for cause) of the engagement period of the
Representative, provided that such Tail Financing is by a party actually introduced to the Company in an offering in which the Company
has direct knowledge of such party’s participation.

No fee shall